Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Cost-Effectiveness Research Fund Provision Included In Medicare Bill

This article was originally published in The Gray Sheet

Executive Summary

The Agency for Healthcare Research & Quality would develop a cost-effectiveness research agenda under the Medicare reform conference agreement

You may also be interested in...



Device Industry Mindful Of AHRQ Cost-Effectiveness Agenda, Due June 8

The device industry will discuss with AHRQ the need to consider long-term costs of new technology underutilization as the agency develops its cost-effectiveness research agenda

Device Industry Mindful Of AHRQ Cost-Effectiveness Agenda, Due June 8

The device industry will discuss with AHRQ the need to consider long-term costs of new technology underutilization as the agency develops its cost-effectiveness research agenda

“Non-Burdensome” Cost-Effectiveness Trials Require Docs’ Help – McClellan

The medical community can help CMS develop real-world data about the use of new medical technologies, agency Administrator Mark McClellan told an American Medical Association conference in Washington, D.C. March 30

Related Content

UsernamePublicRestriction

Register

MT019349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel